Clinical Trials
- Prostate Cancer, Phase 1 Cancers
test
- Ages18 years and older
- GenderMale only
- Prostate Cancer
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Ages18 years and older
- GenderMale only
- Prostate Cancer
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
- Ages18 years - 80 years
- GenderMale only
- Prostate Cancer
test
- Ages30 years - 80 years
- GenderBoth